1. Home
  2. REAX vs EOLS Comparison

REAX vs EOLS Comparison

Compare REAX & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REAX
  • EOLS
  • Stock Information
  • Founded
  • REAX 2018
  • EOLS 2012
  • Country
  • REAX United States
  • EOLS United States
  • Employees
  • REAX N/A
  • EOLS N/A
  • Industry
  • REAX
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • REAX
  • EOLS Health Care
  • Exchange
  • REAX Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • REAX 909.7M
  • EOLS 854.0M
  • IPO Year
  • REAX N/A
  • EOLS 2018
  • Fundamental
  • Price
  • REAX $4.06
  • EOLS $12.03
  • Analyst Decision
  • REAX Strong Buy
  • EOLS Strong Buy
  • Analyst Count
  • REAX 2
  • EOLS 4
  • Target Price
  • REAX $6.00
  • EOLS $24.67
  • AVG Volume (30 Days)
  • REAX 886.5K
  • EOLS 710.0K
  • Earning Date
  • REAX 03-06-2025
  • EOLS 03-04-2025
  • Dividend Yield
  • REAX N/A
  • EOLS N/A
  • EPS Growth
  • REAX N/A
  • EOLS N/A
  • EPS
  • REAX N/A
  • EOLS N/A
  • Revenue
  • REAX $1,264,639,000.00
  • EOLS $266,274,000.00
  • Revenue This Year
  • REAX $26.91
  • EOLS $34.56
  • Revenue Next Year
  • REAX $19.13
  • EOLS $32.26
  • P/E Ratio
  • REAX N/A
  • EOLS N/A
  • Revenue Growth
  • REAX 83.50
  • EOLS 31.76
  • 52 Week Low
  • REAX $3.01
  • EOLS $9.25
  • 52 Week High
  • REAX $6.75
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • REAX 34.11
  • EOLS 35.16
  • Support Level
  • REAX $4.26
  • EOLS $11.59
  • Resistance Level
  • REAX $4.66
  • EOLS $13.66
  • Average True Range (ATR)
  • REAX 0.19
  • EOLS 0.55
  • MACD
  • REAX -0.02
  • EOLS -0.15
  • Stochastic Oscillator
  • REAX 13.14
  • EOLS 21.26

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: